Clinical trial
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
NCT00851929
Study timeline
Study start (unknown)2008-11-01Date precision: month
Registry last updated2018-08-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Sarcoidosisunresolved
Pulmonary Hypertensionunresolved
Interventions
AmbrisentanDRUG · verified · RxNorm: ambrisentan
Sponsors & collaborators
Medical University of South Carolinalead sponsor
Gilead Sciencescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00851929 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.